370 related articles for article (PubMed ID: 21191688)
21. Exclusive Association of p53 Mutation with Super-High Methylation of Tumor Suppressor Genes in the p53 Pathway in a Unique Gastric Cancer Phenotype.
Waraya M; Yamashita K; Ema A; Katada N; Kikuchi S; Watanabe M
PLoS One; 2015; 10(10):e0139902. PubMed ID: 26447864
[TBL] [Abstract][Full Text] [Related]
22. DNA Methylation and Genetic Aberrations in Gastric Cancer.
Usui G; Matsusaka K; Mano Y; Urabe M; Funata S; Fukayama M; Ushiku T; Kaneda A
Digestion; 2021; 102(1):25-32. PubMed ID: 33070127
[TBL] [Abstract][Full Text] [Related]
23. Helicobacter pylori causes epigenetic dysregulation of FOXD3 to promote gastric carcinogenesis.
Cheng AS; Li MS; Kang W; Cheng VY; Chou JL; Lau SS; Go MY; Lee CC; Ling TK; Ng EK; Yu J; Huang TH; To KF; Chan MW; Sung JJ; Chan FK
Gastroenterology; 2013 Jan; 144(1):122-133.e9. PubMed ID: 23058321
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic alterations of CYLD promoter modulate its expression in gastric adenocarcinoma: A footprint of infections.
Ghadami E; Nikbakhsh N; Fattahi S; Kosari-Monfared M; Ranaee M; Taheri H; Amjadi-Moheb F; Godazandeh G; Shafaei S; Nosrati A; Pilehchian Langroudi M; Samadani AA; Amirbozorgi G; Mirnia V; Akhavan-Niaki H
J Cell Physiol; 2019 Apr; 234(4):4115-4124. PubMed ID: 30132887
[TBL] [Abstract][Full Text] [Related]
25. Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer.
Tamura G
World J Gastroenterol; 2006 Jan; 12(2):192-8. PubMed ID: 16482617
[TBL] [Abstract][Full Text] [Related]
26. Autophagy impairment by Helicobacter pylori-induced methylation silencing of MAP1LC3Av1 promotes gastric carcinogenesis.
Muhammad JS; Nanjo S; Ando T; Yamashita S; Maekita T; Ushijima T; Tabuchi Y; Sugiyama T
Int J Cancer; 2017 May; 140(10):2272-2283. PubMed ID: 28214334
[TBL] [Abstract][Full Text] [Related]
27. [Studies of promoter methylation status and protein expression of E-cadherin gene in associated progression stages of gastric cancer].
Zheng ZH; Sun XJ; Ma MC; Hao DM; Liu YH; Sun KL
Yi Chuan Xue Bao; 2003 Feb; 30(2):103-8. PubMed ID: 12776596
[TBL] [Abstract][Full Text] [Related]
28. Cooperative participation of epigenomic and genomic alterations in the clinicopathological diversity of gastric adenocarcinomas: significance of cell adhesion and epithelial-mesenchymal transition-related signaling pathways.
Yang M; Arai E; Takahashi Y; Totsuka H; Chiku S; Taniguchi H; Katai H; Sakamoto H; Yoshida T; Kanai Y
Carcinogenesis; 2020 Nov; 41(11):1473-1484. PubMed ID: 32710740
[TBL] [Abstract][Full Text] [Related]
29. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.
Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG
Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730
[TBL] [Abstract][Full Text] [Related]
30. CpG island promoter methylation (CIHM) status of tumor suppressor genes correlates with morphological appearances of gastric cancer.
Tahara T; Shibata T; Arisawa T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Maeda Y; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Hirata I
Anticancer Res; 2010 Jan; 30(1):239-44. PubMed ID: 20150642
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of mutant p53 and c-erbB-2 proteins and mutations of the p15 and p16 genes in human gastric carcinoma: with respect to histological subtypes and stages.
Wu MS; Shun CT; Sheu JC; Wang HP; Wang JT; Lee WJ; Chen CJ; Wang TH; Lin JT
J Gastroenterol Hepatol; 1998 Mar; 13(3):305-10. PubMed ID: 9570245
[TBL] [Abstract][Full Text] [Related]
32. Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein-Barr virus.
Kusano M; Toyota M; Suzuki H; Akino K; Aoki F; Fujita M; Hosokawa M; Shinomura Y; Imai K; Tokino T
Cancer; 2006 Apr; 106(7):1467-79. PubMed ID: 16518809
[TBL] [Abstract][Full Text] [Related]
33. Mediation of the malignant biological characteristics of gastric cancer cells by the methylated CpG islands in RNF180 DNA promoter.
Deng J; Guo J; Guo X; Hou Y; Xie X; Sun C; Zhang R; Yu X; Liang H
Oncotarget; 2016 Jul; 7(28):43461-43474. PubMed ID: 27223257
[TBL] [Abstract][Full Text] [Related]
34. Promoter methylations of p16INK4a and p14ARF genes in early and advanced gastric cancer. Correlations of the modes of their occurrence with histologic type.
Tsujimoto H; Hagiwara A; Sugihara H; Hattori T; Yamagishi H
Pathol Res Pract; 2002; 198(12):785-94. PubMed ID: 12608655
[TBL] [Abstract][Full Text] [Related]
35. Frequent monoallelic deletion of PTEN and its reciprocal associatioin with PIK3CA amplification in gastric carcinoma.
Byun DS; Cho K; Ryu BK; Lee MG; Park JI; Chae KS; Kim HJ; Chi SG
Int J Cancer; 2003 Apr; 104(3):318-27. PubMed ID: 12569555
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic clustering of gastric carcinomas based on DNA methylation profiles at the precancerous stage: its correlation with tumor aggressiveness and patient outcome.
Yamanoi K; Arai E; Tian Y; Takahashi Y; Miyata S; Sasaki H; Chiwaki F; Ichikawa H; Sakamoto H; Kushima R; Katai H; Yoshida T; Sakamoto M; Kanai Y
Carcinogenesis; 2015 May; 36(5):509-20. PubMed ID: 25740824
[TBL] [Abstract][Full Text] [Related]
37. Methylation subtypes and large-scale epigenetic alterations in gastric cancer.
Zouridis H; Deng N; Ivanova T; Zhu Y; Wong B; Huang D; Wu YH; Wu Y; Tan IB; Liem N; Gopalakrishnan V; Luo Q; Wu J; Lee M; Yong WP; Goh LK; Teh BT; Rozen S; Tan P
Sci Transl Med; 2012 Oct; 4(156):156ra140. PubMed ID: 23076357
[TBL] [Abstract][Full Text] [Related]
38. [Gastric cancer: histological type, histogenesis, and gene abnormalities].
Tamura G
Gan To Kagaku Ryoho; 2008 Feb; 35(2):343-9. PubMed ID: 18281780
[TBL] [Abstract][Full Text] [Related]
39. The impact of DNA demethylation on the upregulation of the NRN1 and TNFAIP3 genes associated with advanced gastric cancer.
Wisnieski F; Santos LC; Calcagno DQ; Geraldis JC; Gigek CO; Anauate AC; Chen ES; Rasmussen LT; Payão SLM; Artigiani R; Demachki S; Assumpção PP; Lourenço LG; Arasaki CH; Pabinger S; Krainer J; Leal MF; Burbano RR; Arruda Cardoso Smith M
J Mol Med (Berl); 2020 May; 98(5):707-717. PubMed ID: 32285140
[TBL] [Abstract][Full Text] [Related]
40. Gastric Carcinogenesis and Underlying Molecular Mechanisms: Helicobacter pylori and Novel Targeted Therapy.
Nishizawa T; Suzuki H
Biomed Res Int; 2015; 2015():794378. PubMed ID: 25945346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
